Fig 1 -Iron homeostasis. Suggested iron and copper traffic in the bloodstream. Ferroportin (blue) is expressed on the membrane surface of iron releasing cells (enterocytes, hepatocytes, and macrophages), allowing the iron ions (yellow) to exit the cell (yellow arrow) and bind transferrin (pink) for transport through the blood stream. Circulating hepcidin-25 (red) blocks the iron export by binding to ferroportin. Copper ions (green) released from intestinal cells are bound by various molecules in the blood. Iron and copper ions are exchanged between various complexing agents based on chemical affinities and biological needs. Fig 2 -Hepcidin-25 sequences of various species. The first 6-residue sequence is delimited (green line
)
Fig. 5 -Full scan (MS) and product ion spectra (MS/MS) of hepcidin-25 complexed with two Cu(II) ions

Fig. 6 -FTICR-MS spectra of the triply charged ion of hepcidin-25 complexed with A. one copper ion [M+H+Cu] 3+ and B. two copper ions [M+H+2Cu] 3+ (pH=11). The experimentally determined spectrum (a) is compared to the theoretical isotope pattern (b).
Fig. 7 -FTICR-MS spectra of the triply charged ion of hepcidin-25 complexed with one copper ion [M+H+Cu] 3+ (pH=7.4). The experimentally determined spectrum (a) is compared to the theoretical isotope pattern (b).
complex (red) and uncomplexed peptide (blue). The largest chemical shift perturbation was observed for the N-terminal amino acids Asp-1, Thr-2, and His-3. Resonance assignment of A) the aliphatic and B) the aromatic region. * contains a double set of peaks for each amino acid and suggest a presence of cis-trans proline isomerization.
Fig . 9 -The copper-free and copper-bound forms of the DTHFPI peptide are in slow exchange. 
H NMR spectra of the metal-hexapeptide complex in the presence of 0.5 copper(II) equivalent (red) and uncomplexed peptide (blue
